ZA904353B - Use of a polypeptide having the activity of human interleukin 2 for preparing a pharmaceutical composition intended for the treatment of primary cancers of the pleura - Google Patents

Use of a polypeptide having the activity of human interleukin 2 for preparing a pharmaceutical composition intended for the treatment of primary cancers of the pleura

Info

Publication number
ZA904353B
ZA904353B ZA904353A ZA904353A ZA904353B ZA 904353 B ZA904353 B ZA 904353B ZA 904353 A ZA904353 A ZA 904353A ZA 904353 A ZA904353 A ZA 904353A ZA 904353 B ZA904353 B ZA 904353B
Authority
ZA
South Africa
Prior art keywords
pleura
polypeptide
activity
preparing
human interleukin
Prior art date
Application number
ZA904353A
Other languages
English (en)
Inventor
Maud Brandely
Brandely Maud
Danielle Lando
Lando Danielle
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of ZA904353B publication Critical patent/ZA904353B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA904353A 1990-04-17 1990-06-06 Use of a polypeptide having the activity of human interleukin 2 for preparing a pharmaceutical composition intended for the treatment of primary cancers of the pleura ZA904353B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9004895A FR2660863B1 (fr) 1990-04-17 1990-04-17 Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour preparer une composition pharmaceutique destinee au traitement de cancers primitifs de la plevre.

Publications (1)

Publication Number Publication Date
ZA904353B true ZA904353B (en) 1991-08-28

Family

ID=9395818

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA904353A ZA904353B (en) 1990-04-17 1990-06-06 Use of a polypeptide having the activity of human interleukin 2 for preparing a pharmaceutical composition intended for the treatment of primary cancers of the pleura

Country Status (13)

Country Link
US (1) US5219565A (de)
EP (1) EP0452598B1 (de)
JP (1) JP2848922B2 (de)
KR (1) KR0165674B1 (de)
AT (1) ATE97575T1 (de)
AU (1) AU631649B2 (de)
CA (1) CA2018630A1 (de)
DE (1) DE69004794T2 (de)
DK (1) DK0452598T3 (de)
FR (1) FR2660863B1 (de)
HU (1) HU205261B (de)
OA (1) OA09213A (de)
ZA (1) ZA904353B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2668368B1 (fr) * 1990-10-30 1995-03-10 Roussel Uclaf Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour preparer une composition pharmaceutique destinee au traitement des tumeurs malignes epitheliales.
FR2671728B1 (fr) * 1991-01-17 1995-01-20 Roussel Uclaf Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour la preparation de compositions pharmaceutiques destinees au traitement des pneumathorax.
FR2684878B1 (fr) * 1991-12-12 1994-02-11 Roussel Uclaf Composition pharmaceutique stabilisee d'il2 humaine recombinante non glycosylee sous forme reduite et son procede de preparation.
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5696079A (en) * 1993-05-19 1997-12-09 The United States Of America As Represented By The Department Of Health And Human Services Immunologic enhancement with intermittent interleukin-2 therapy
US5419900A (en) 1993-05-19 1995-05-30 The United States Of America As Represented By The Department Of Of Health And Human Services Immunologic enhancement with intermittent interleukin-2 therapy
EP2206720A1 (de) * 2000-04-12 2010-07-14 Human Genome Sciences, Inc. Albuminfusionsproteine
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
WO2002097038A2 (en) * 2001-05-25 2002-12-05 Human Genome Sciences, Inc. Chemokine beta-1 fusion proteins
EP2261250B1 (de) 2001-12-21 2015-07-01 Human Genome Sciences, Inc. GCSF-Albumin Fusionsproteine
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
EP4419143A4 (de) * 2021-10-20 2025-10-08 Univ Rice William M Verfahren zur verwendung und verabreichung von verkapselten zellen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0031539B1 (de) * 1979-12-28 1987-03-25 International Business Machines Corporation Potential-Verteilungssystem eines LSI-Chips
FR2635527B1 (fr) * 1988-07-28 1992-06-12 Roussel Uclaf Il2 humaine recombinante non glycosylee sous forme reduite, son procede d'obtention et son application comme medicament

Also Published As

Publication number Publication date
FR2660863B1 (fr) 1994-01-21
HU205261B (en) 1992-04-28
AU631649B2 (en) 1992-12-03
OA09213A (fr) 1992-06-30
JP2848922B2 (ja) 1999-01-20
DE69004794T2 (de) 1994-04-14
HU903769D0 (en) 1990-11-28
KR0165674B1 (ko) 1999-01-15
JPH045241A (ja) 1992-01-09
FR2660863A1 (fr) 1991-10-18
HUT56721A (en) 1991-10-28
CA2018630A1 (fr) 1991-10-17
EP0452598A1 (de) 1991-10-23
DE69004794D1 (de) 1994-01-05
ATE97575T1 (de) 1993-12-15
EP0452598B1 (de) 1993-11-24
KR910018038A (ko) 1991-11-30
AU5693590A (en) 1991-11-21
US5219565A (en) 1993-06-15
DK0452598T3 (da) 1994-01-17

Similar Documents

Publication Publication Date Title
ZA904353B (en) Use of a polypeptide having the activity of human interleukin 2 for preparing a pharmaceutical composition intended for the treatment of primary cancers of the pleura
AU6466790A (en) Use of a polypeptide having the activity of human interleukine 2 for the preparation of pharmaceutical compositions intended for the treatment of leukemias
EP0271211A3 (en) Use of cartilage-inducing factor b (cif-b) for the manufacture of a medicament for inhibiting tumor growth
DK193887A (da) Peptid med bronchodilartorisk og hypotensiv aktivitet
GR3035682T3 (en) Non-glycosylated fgf-4 and compositions containing the same.
EP0553294A4 (en) Methods and compositions for the treatment of cell proliferation disorders
IL97054A0 (en) Pharmaceutical compositions comprising buspirones for the treatment of sleep apneas
DE3572441D1 (en) Use of interferon gamma (ifn-gamma) for the production of preparations for treating rheumatic diseases
HUT63575A (en) Stabilized pharmaceutical composition comprising the reduced form of non-glycosylated, recombinant human interleukin-2
AU7052191A (en) Antitumoral composition based on polypeptides having human interleukin 2 activity
ZA932830B (en) A novel anti-neoplastic cytokine
HUT60145A (en) Process for producing pharmaceutical composition comprising human interleukin-2 and suitable for treating pneumothorax
EP0495226A3 (en) 3-aryl-5-alkylthio-4h-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma
NZ226360A (en) Antiviral and antitumoural composition containing 2,6 diamino-3-phenyl-3-phenylazo-pyridine
IL94417A0 (en) Pharmaceutical compositions containing gestodene and methods for the preparation and use thereof
AU645042B2 (en) Use of a polypeptide having the activity of gamma interferon for the preparation of pharmaceutical compositions intended for the treatment of primary cancers of the pleura
EP0271447A3 (en) Preventive measures for preventing the "bovine complex respiratory disease" by administering interferon
EP0381584A3 (de) Verwendung bestimmter gamma-Interferone zur Behandlung von Krebs des Ovars